Epidermolytic hyperkeratosis type NPS-3: A case report

Acta Dermatovenerologica Croatica

Volumn 15, Issue 1, 2007, Pages 20-23

  Prohić, Asja ^a   Selmanagić, Almira ^a   Bilalović, Nurija ^a  

^a UNIVERSITY OF SARAJEVO   (Bosnia and Herzegovina)

Author keywords

Epidermolytic hyperkeratosis; Type NPS 3

Indexed keywords

ANAMNESIS; ARTICLE; BLOOD ANALYSIS; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; EPIDERMOLYTIC HYPERKERATOSIS TYPE NPS 3; FEMALE; HISTOPATHOLOGY; HUMAN; HYPERKERATOSIS; LABORATORY TEST; PHYSICAL EXAMINATION; SCHOOL CHILD; SKIN BIOPSY; SYMPTOMATOLOGY;

CHILD; FEMALE; HUMANS; HYPERKERATOSIS, EPIDERMOLYTIC;

EID: 34247486982     PISSN: 1330027X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Shwayder T. Disorders of keratinization. Am J Clin Dermatol 2004;5:17-29.
2. Otley CC, Gellis S. Epidermolytic hyperkeratosis. Int J Dermatol 1996;35:579-81.
3. Ammirati CT, Mallory SB. The major inherited disorders of cornification. Dermatol Clin 1998;16:497-508.
4. Bale SJ, Compton DG, DiGiovanna JJ. Epidermolytic hyperkeratosis. Semin Dermatol 1993;12:202-9.
5. Uezato H, Yamamoto Y, Kuwae C, Nonaka K, Oshiro M, Kariya K, et al. A case of bullous congenital ichthyosiform erythroderma (BCIE) caused by a mutation in the 1A helix initiation motif of keratin 1. J Dermatol 2005;32:801-8.
6. Sun XK, Ma LL, Xie YQ, Zhu XJ. Keratin 1 and keratin 10 mutations causing epidermolytic hyperkeratosis in Chinese patients. J Dermatol Sci 2002;29:195-200.
7. DiGiovanna JJ, Bale SJ. Clinical heterogeneity in epidermolytic hyperkeratosis. Arch Dermatol 1994;130:1026-35.
8. DiGiovanna JJ, Robinson-Bostom L. Ichthyosis: etiology, diagnosis, and management. Am J Clin Dermatol 2003;4:81-95.
9. Brocq L. Erythrodermie conginitale ichthyosiforme avec hyperepidermotrophie. Ann Dermatol Syphiligr 1902;4:1-31.
10. Baleviciene G, Schwartz RA. Epidermolytic hyperkeratosis with ichthyosis hystrix. Cutis 2000;66:319-22.
11. Rothangel JA, Dominey AM, Dempsy MD Longley MA, Greenhalgh DA, Gagne TA, et al. Mutations in the rod domains of keratins 1 and 10 in epidermolytic hyperkeratosis. Science 1992 21;257:1128-30.
12. Lacz NL, Schwartz AR, Kihiczak G. Epidermolytic hyperkeratosis: a keratin 1 or 10 mutational event. Int J Dermatol 2005;44:1-6.
13. Ishida-Yamamoto A, Takahashi H, Iizuka H. Lessons from disorders of epidermal differentiation-associated keratins. Histol Histopathol 2002;17:331-8.
14. Schmurth M, Yospovitch G, Williams ML, Weber F, Hintner H, Ortiz-Urda S, et al. Pathogenesis of permeability barrier abnormality in epidermolytic hyperkeratosis. J Invest Dermatol 2001;117:837-47.
15. Kumar S, Sehgal VN, Sharma RC. Epidermolytic hyperkeratosis. Int J Dermatol 1999;38:914-5.
16. Tosti A, Fanti PA, Piraccini BM, Bardazzi F, Misciali C. Epidermolytic hyperkeratosis of the nails in keratosis palmoplantaris nummularis. Acta Derm Venereol 1995;75:405-6.
17. Muramatsu S, Suga Y, Mizuno Y, Hasegawa T, Tsuchihashi H, Matsuba S. A novel threonine to proline mutation in the helix termination motif of keratin 1 in epidermolytic hyperkeratosis with severe palmoplantar hyperkeratosis and contractures of the digits. Br J Dermatol 2005 May; 152(5):1087-9.
18. DiGiovanna JJ, Bale SJ. Epidermolytic hyperkeratosis: applied molecular genetics. J Invest Dermatol 1994;102:390-4.
19. Yang JM, Nam K, Kim SW, Jung SY, Min HG, Yeo UC, et al. Arginine in the beginning of the 1A rod domain of the keratin 10 gene is the hot spot for the mutation in epidermolytic hyperkeratosis. J Dermatol Sci 1999;19:126-33.
20. Ishida-Yamamoto A, McGrath JA, Judge MR, Leigh IM, Mance EB, Eady RA. Selective involvement of keratins K1 and K10 in the cytoskeletal abnormality of epidermolytic hyperkeratosis (bullous congenital ichthyosiform erythroderma). J Invest Dermatol 1992 Jul;99(1):19-26.
21. Rothnagel JA, Lin MT, Longley MA, Holden RA, Hazen PG, Levy ML, et al. Prenatal diagnosis for keratin mutations to exclude transmission of epidermolytic hyperkeratosis. Prenat Diagn 1998 Aug;18(8):826-30.
22. Kempers S, Katz HI, Wildnauer R, Green B. An evaluation of the effect of an alpha hydroxy acid-blend skin cream in the cosmetic improvement of symptoms of moderate to severe xerosis, epidermolytic hyperkatosis and ichthyosis. Cutis 1998;61:347-50.
23. Bogenrieder T, Landthaler M, Stolz W. Bullous congenital ichthyosiform erythroderma: safe and effective topical treatment with calcipotriol ointment in a child. Acta Derm Venereol 2003;83:52-4.
24. Lacour M, Mehta-Nikhar B, Artherton DJ, Harper JI. An appraisal of acitretin therapy in children with inherited disorder of keratinization. Br J Dermatol 1996;134:1023-9.
25. Nychay SG, Khorenia SD, Schwartz RA, Janniger CK, Lambert WC, Kihiczak G. Epidermolytic hyperkeratosis treated with etretinate. Cutis 1991;47:277-80.
26. Virtanen M, Gedde-Dahl T Jr, Mork NJ, Leigh I, Bowden PE, Vahlquist A. Phenotypic/genotypic correlations in patients with epidermolytic hyperkeratosis and the effects of retinoid therapy on keratin expression. Acta Derm Venereol 2001;81:163-70.